RxDoctor Payments Data
★ My doctorsLook up a doctor →

Ariel Bryant

Rheumatology · Covina, CANPI 1578106597

Payments from drug & device makers

$17,409in general payments, 2019–2025

Across 880 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Johnson & Johnson$2K
  • Amgen$2K
  • UCB, Inc.$2K
  • AstraZeneca$2K
  • Novartis$1K
  • plus $6K from 35 others

What the payments were for

  • Food & beverage$17,06698%
  • Education$3432%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie146$2,774
Johnson & Johnson(2 entities)113$2,333
Amgen(2 entities)108$1,915
UCB, Inc.104$1,880
AstraZeneca(2 entities)80$1,655
Novartis68$1,313
GSK66$1,177
Mallinckrodt Hospital Products Inc.45$991
Lilly USA, LLC29$518
Aurinia Pharma U.S., Inc.13$312
Pfizer12$230
ANI Pharmaceuticals, Inc.10$199
Organon10$180
Radius Health, Inc.7$171
Sanofi-aventis U.S. LLC4$146
Boehringer Ingelheim6$144
Kiniksa Pharmaceuticals, Ltd.3$139
Currax Pharmaceuticals LLC9$126
Cumberland Pharmaceuticals, Inc.3$119
E.r. Squibb & Sons, L.L.C.5$119
Janssen Scientific Affairs, LLC1$116
Fresenius Kabi USA, LLC4$113
Sobi, Inc4$93
Sanofi2$86
Kiniksa Pharmaceuticals International, PLC3$69
Scilex Pharmaceuticals Inc.3$56
Impel Pharmaceuticals Inc.3$52
Teva Pharmaceuticals USA, Inc.2$49
Hikma Pharmaceuticals USA3$43
Tonix Medicines, Inc.1$39
Celltrion USA Inc.2$37
Ultragenyx Pharmaceutical Inc.2$35
Kyowa Kirin, Inc.1$28
Arbor Pharmaceuticals, Inc.1$24
Oyster Point Pharma, Inc.1$22
Novo Nordisk1$20
Pacira Pharmaceuticals Incorporated1$20
Atricure, Inc.1$20
Biohaven Pharmaceuticals, Inc.1$20
Octapharma USA, Inc.1$14
Azurity Pharmaceuticals, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,409 in reported general payments places this provider in the 75th percentile of 808 rheumatology providers in California.

See all rheumatology providers in California →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Leflunomide56$5,620
Lidocaine115$5,013
Diclofenac Sodium77$4,760
Hydroxychloroquine Sulfate165$4,010
MethotrexateMethotrexate Sodium131$3,762
Pregabalin131$2,188
Duloxetine Hcl113$2,187
Mycophenolate Mofetil14$1,792
Baclofen159$981
Celecoxib56$823
Gabapentin113$769
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen48$748
Sulfasalazine35$699
Prednisone179$649
Alendronate Sodium109$541

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Scilex Pharmaceuticals Inc.Colchicine$56$29212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 808 rheumatology providers in California.

Other rheumatology in Covina

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →